| Q61799106 | 2-aminoimidazoles collapse mycobacterial proton motive force and block the electron transport chain |
| Q41293939 | 2-aminoimidazoles potentiate ß-lactam antimicrobial activity against Mycobacterium tuberculosis by reducing ß-lactamase secretion and increasing cell envelope permeability. |
| Q28473609 | A Mycobacterium tuberculosis sigma factor network responds to cell-envelope damage by the promising anti-mycobacterial thioridazine |
| Q47112934 | A Novel TetR-Like Transcriptional Regulator Is Induced in Acid-Nitrosative Stress and Controls Expression of an Efflux Pump in Mycobacteria |
| Q28475648 | A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen |
| Q39661161 | AccD6, a key carboxyltransferase essential for mycolic acid synthesis in Mycobacterium tuberculosis, is dispensable in a nonpathogenic strain |
| Q93088191 | Action of Dicumarol on Glucosamine-1-Phosphate Acetyltransferase of GlmU and Mycobacterium tuberculosis |
| Q48515500 | Acute modulation of mycobacterial cell envelope biogenesis by front-line TB drugs |
| Q33613751 | Altered protein expression patterns of Mycobacterium tuberculosis induced by ATB107. |
| Q36672684 | Application of functional genomics to pathway optimization for increased isoprenoid production. |
| Q37409999 | Basic concepts of microarrays and potential applications in clinical microbiology |
| Q38700240 | Biochemical Investigation of Rv3404c from Mycobacterium tuberculosis |
| Q54260763 | Comparison of gene expression profiles between pansensitive and multidrug-resistant strains of Mycobacterium tuberculosis. |
| Q39614772 | Conditional depletion of KasA, a key enzyme of mycolic acid biosynthesis, leads to mycobacterial cell lysis. |
| Q36101770 | Determining the mode of action of anti-mycobacterial C17 diyne natural products using expression profiling: evidence for fatty acid biosynthesis inhibition |
| Q33803840 | Discovering the mechanism of action of novel antibacterial agents through transcriptional profiling of conditional mutants |
| Q53682441 | Dissecting the Acid Stress Response of Rhizobium tropici CIAT 899. |
| Q28475676 | Drug discovery using chemical systems biology: repositioning the safe medicine Comtan to treat multi-drug and extensively drug resistant tuberculosis |
| Q30394670 | Dual-Reporter Mycobacteriophages (Φ2DRMs) Reveal Preexisting Mycobacterium tuberculosis Persistent Cells in Human Sputum |
| Q28543543 | Efflux pump gene expression in multidrug-resistant Mycobacterium tuberculosis clinical isolates |
| Q36138147 | Efflux-mediated antimicrobial resistance |
| Q39769328 | Examining the basis of isoniazid tolerance in nonreplicating Mycobacterium tuberculosis using transcriptional profiling. |
| Q35012666 | Exploring drug action on Mycobacterium tuberculosis using affymetrix oligonucleotide genechips |
| Q35879195 | Functional complementation of the essential gene fabG1 of Mycobacterium tuberculosis by Mycobacterium smegmatis fabG but not Escherichia coli fabG |
| Q47599430 | Gene expression profiling of the response of Streptococcus pneumoniae to penicillin |
| Q91703896 | Gene expression responses to anti-tuberculous drugs in a whole blood model |
| Q64128191 | Genome-Wide Transcriptional Responses of to Antibiotics |
| Q33761987 | Genome-wide transcription analyses in Mycobacterium tuberculosis treated with lupulone |
| Q33327381 | Genomic diversity among Beijing and non-Beijing Mycobacterium tuberculosis isolates from Myanmar |
| Q28487032 | Global expression profiling of strains harbouring null mutations reveals that the five rpf-like genes of Mycobacterium tuberculosis show functional redundancy |
| Q38327291 | Global transcriptional response of Bacillus subtilis to treatment with subinhibitory concentrations of antibiotics that inhibit protein synthesis |
| Q36863134 | Immune activation of the host cell induces drug tolerance in Mycobacterium tuberculosis both in vitro and in vivo. |
| Q33770118 | Immunoproteomic identification of human T cell antigens of Mycobacterium tuberculosis that differentiate healthy contacts from tuberculosis patients |
| Q56770315 | Microarray analysis of the chelerythrine-induced transcriptome of Mycobacterium tuberculosis |
| Q80221973 | Microarrays for Mycobacterium tuberculosis |
| Q38170188 | MmpL3 a potential new target for development of novel anti-tuberculosis drugs |
| Q42704871 | Modeling metabolic adjustment in Mycobacterium tuberculosis upon treatment with isoniazid |
| Q92394080 | Modeling of Mycobacterium tuberculosis dormancy in bacterial cultures |
| Q36223232 | Mycobacterium tuberculosis WhiB4 regulates oxidative stress response to modulate survival and dissemination in vivo. |
| Q33995482 | Mycobacterium tuberculosis dihydrofolate reductase is a target for isoniazid |
| Q38266496 | Mycobacterium tuberculosis enoyl-acyl carrier protein reductase inhibitors as potential antituberculotics: development in the past decade. |
| Q36772385 | Natural product growth inhibitors of Mycobacterium tuberculosis. |
| Q21089606 | Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs |
| Q90306427 | Potential impact of efflux pump genes in mediating rifampicin resistance in clinical isolates of Mycobacterium tuberculosis from India |
| Q42720655 | Preliminary investigations of the effect of lipophilic analogues of the active metabolite of isoniazid toward bacterial and plasmodial strains. |
| Q36845726 | Proteome-wide profiling of isoniazid targets in Mycobacterium tuberculosis |
| Q38989303 | Recent Advances and Structural Features of Enoyl-ACP Reductase Inhibitors of Mycobacterium tuberculosis |
| Q38097123 | Recycling and refurbishing old antitubercular drugs: the encouraging case of inhibitors of mycolic acid biosynthesis |
| Q41225370 | Role of long-chain acyl-CoAs in the regulation of mycolic acid biosynthesis in mycobacteria. |
| Q36378353 | Role of mycobacterial efflux transporters in drug resistance: an unresolved question |
| Q35153938 | Sub-inhibitory fosmidomycin exposures elicits oxidative stress in Salmonella enterica serovar Typhimurium LT2. |
| Q89531904 | TbD1 deletion as a driver of the evolutionary success of modern epidemic Mycobacterium tuberculosis lineages |
| Q54211667 | The Mycobacterium tuberculosis Complex has a Pathway for the Biosynthesis of 4-Formamido-4,6-Dideoxy-d-Glucose. |
| Q33615471 | The Mycobacterium tuberculosis cytochrome P450 system |
| Q28487203 | The essential mycobacterial genes, fabG1 and fabG4, encode 3-oxoacyl-thioester reductases that are functional in yeast mitochondrial fatty acid synthase type 2 |
| Q47215316 | The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action |
| Q47133547 | The transcriptome of Mycobacterium tuberculosis in a lipid-rich dormancy model through RNAseq analysis. |
| Q44944734 | The use of microarray analysis to determine the gene expression profiles of Mycobacterium tuberculosis in response to anti-bacterial compounds. |
| Q47916958 | The α1β1 region is crucial for biofilm enhancement activity of MTC28 in Mycobacterium smegmatis |
| Q40752382 | Toxicogenomic response of Rhodospirillum rubrum S1H to the micropollutant triclosan |
| Q35993510 | Transcriptional Adaptation of Drug-tolerant Mycobacterium tuberculosis During Treatment of Human Tuberculosis |
| Q42046889 | Triclosan-induced genes Rv1686c-Rv1687c and Rv3161c are not involved in triclosan resistance in Mycobacterium tuberculosis. |
| Q64973298 | Triclosan: An Update on Biochemical and Molecular Mechanisms. |
| Q80062567 | Understanding the action of INH on a highly INH-resistant Mycobacterium tuberculosis strain using Genechips |
| Q36280830 | Using microarray gene signatures to elucidate mechanisms of antibiotic action and resistance |
| Q21202793 | targetTB: a target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis |
Search more.